- Home
- BOLD vs SCNX Comparison
BOLD vs SCNX Comparison
Compare BOLD & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- SCNX
- Stock Information
- Founded
- BOLD 2018
- SCNX 2010
- Country
- BOLD United States
- SCNX United States
- Employees
- BOLD N/A
- SCNX N/A
- Industry
- BOLD
- SCNX Other Pharmaceuticals
- Sector
- BOLD
- SCNX Health Care
- Exchange
- BOLD Nasdaq
- SCNX Nasdaq
- Market Cap
- BOLD 24.4M
- SCNX 21.2M
- IPO Year
- BOLD 2024
- SCNX 2020
- Fundamental
- Price
- BOLD $1.15
- SCNX $0.94
- Analyst Decision
- BOLD Buy
- SCNX
- Analyst Count
- BOLD 4
- SCNX 0
- Target Price
- BOLD $4.00
- SCNX N/A
- AVG Volume (30 Days)
- BOLD 79.9K
- SCNX 298.5K
- Earning Date
- BOLD 11-06-2025
- SCNX 11-05-2025
- Dividend Yield
- BOLD N/A
- SCNX N/A
- EPS Growth
- BOLD N/A
- SCNX N/A
- EPS
- BOLD N/A
- SCNX N/A
- Revenue
- BOLD N/A
- SCNX $128,202.00
- Revenue This Year
- BOLD N/A
- SCNX N/A
- Revenue Next Year
- BOLD N/A
- SCNX N/A
- P/E Ratio
- BOLD N/A
- SCNX N/A
- Revenue Growth
- BOLD N/A
- SCNX N/A
- 52 Week Low
- BOLD $1.00
- SCNX $0.69
- 52 Week High
- BOLD $4.72
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- BOLD 49.88
- SCNX 33.59
- Support Level
- BOLD $1.13
- SCNX $0.83
- Resistance Level
- BOLD $1.16
- SCNX $0.91
- Average True Range (ATR)
- BOLD 0.04
- SCNX 0.06
- MACD
- BOLD 0.00
- SCNX 0.01
- Stochastic Oscillator
- BOLD 62.50
- SCNX 43.05
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.